Loading…
Loading…
ESVNF (Apptly Health Technologies Corp.) is a recent IPO.
It began trading on March 26, 2026, giving it under six months of public history. Many charts and metrics below are sparse or empty until more price, financial, and analyst history accumulates — the affected sections are flagged individually so you can tell limited history from missing data.
ESVNF does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for ESVNF and 80,000+ other tickers.
See exactly how ESVNF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ESVNF and 80,000+ other tickers.
Apptly Health Technologies Corp. operates a digital healthcare platform in global markets. It offers services that connect patients directly with medical specialists for in-person or virtual consultations, featuring transparent pricing and online booking without the need for insurance or referrals. The company provides access to specialties, such as Cardiology, Dermatology, Orthopedics, and Mental Health, and serves individual patients as well as employers seeking employee health benefits. Apptly Health Technologies Corp. was formerly known as UBERDOC Health Technologies Corp. and changed its name to Apptly Health Technologies Corp. in June 2026. The company is based in Vancouver, Canada.
Builder of the U.S. direct-to-consumer telehealth category joins the physician-founded, surgeon-led marketplace as it scales nationwide direct-pay access Advisor Appointment Vancouver, British Columbia--(Newsfile Corp. - June 23, 2026) - Apptly Health Technologies Corp. (CSE: APPT) (FSE: 4KL0) (the "Company" or "Apptly"), operator of the UberDoc direct-pay healthcare marketplace, is pleased to announce the appointment of Paul Johnson to its advisory board (the "Advisory Board"). Johnson co-founded Lemonaid Health, the first national direct-to-consumer telehealth service in the United States, and led it as Chief Executive Officer through its US$400 million sale to 23andMe in 2021.
Rebrand reflects the Company's evolution into a marketplace for direct-pay specialty care, built on the UberDoc network and a single principle: the appropriate care, at the appropriate price, by the appropriate physician. Boston, Massachusetts--(Newsfile Corp. - June 18, 2026) - UBERDOC Health Technologies Corp. (CSE: APPT) (FSE: 4KL0) (the "Company") is pleased to announce its intention to change its corporate name to Apptly Health Technologies Corp. ("Apptly").
Founder Dr. Paula Muto Named Interim CEO as Company Enters Next Growth Phase Boston, Massachusetts--(Newsfile Corp. - May 15, 2026) - UberDoc Health Technologies Corp. (CSE: APPT) (FSE: 4KL0), a direct-pay healthcare marketplace connecting patients with board-certified specialists at transparent, upfront prices, today announced a leadership transition. Sean Kearney is departing as Chief Executive Officer, and founder Dr. Paula Muto has been named Interim Chief Executive Officer, as of Friday, May 15.
Boston, Massachusetts--(Newsfile Corp. - April 24, 2026) - UberDoc Health Technologies Corp. (CSE: APPT) (FSE: 4KL0), the direct-pay healthcare marketplace for specialty care, today announced that Jeffrey Hogan has stepped down from its Board of Directors. Hogan will focus his attention on the Judi Group, the healthcare advisory firm he co-founded in January 2026 to address fiduciary compliance and cost transparency in employer-sponsored health plans.
Vancouver, British Columbia--(Newsfile Corp. - March 16, 2026) - UBERDOC Health Technologies Corp. (CSE: SEEM) (OTCQB: ESVNF) ("UBERDOC" or the "Company") is pleased to announce that it has completed its previously announced amalgamation effective March 13, 2026 pursuant to an amalgamation agreement dated May 1, 2025 as amended from time to time (the "Amalgamation Agreement") with ROV Investment Partners Corp. ("ROV") and 1536702 B.C. Ltd. ("Subco"), a wholly owned subsidiary of the Company.